
Research Compounds › Research Peptide
CJC-1295 with DAC

CJC-1295 with DAC
Product Description
A long-acting GHRH analog with a Drug Affinity Complex, studied in endocrine research.
CJC-1295 with DAC is a modified GRF(1-29) peptide with an added Drug Affinity Complex (DAC) that binds circulating albumin. This greatly extends its half-life in research models, making it a tool for studying sustained GHRH receptor signaling.
Batch Testing
Every batch listed below has a Certificate of Analysis you can open in our COA lookup. Enter the batch number from your vial.
| Batch | Laboratory | Purity (HPLC) | Report date |
|---|---|---|---|
| CJC-1295W/DAC-1001 | ACS Laboratory | 96.92% | 2026-06-18 |
Specifications
- Form: lyophilized (freeze-dried) powder in a sealed vial
- Fulfillment: shipped from the United States
Storage
Store lyophilized vials refrigerated at 2–8 °C, protected from light and moisture. For longer-term storage, keep at -20 °C. Once reconstituted, keep refrigerated and avoid repeated freeze-thaw cycles. See our storage and handling guide.
Related
- GHRH & GHRP Peptides
- How to Read a Peptide Certificate of Analysis
- GHRH Analogs vs. GHRPs
- Bacteriostatic Water
For laboratory research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease.
Research Use Only
This compound is intended exclusively for laboratory research purposes. Not for human or veterinary use, medical diagnosis, treatment, or prevention of any disease.